British doctors are preparing to conduct the first full-scale clinical trial of a "shock wave" treatment for rheumatism. The treatment has so far been used on chronic calcific tendinitis of the shoulder, in which calcium forms around the joint and tendons and causes great pain. Other joints are susceptible, including the hip, and most sufferers are between 35 and 60 years old.